Wird geladen...
ACS Chemical Neuroscience Molecule Spotlight on Lorcaserin
[Image: see text] Lorcaserin (APD-356) is the first in a new class of selective serotonin 5-hydroxytryptamine(2C) (5-HT(2C)) receptor agonists. On December 22, 2009, the compound's developer (Arena Pharmaceuticals) submitted an NDA to the FDA for approval for weight management.
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Chemical Society
2010
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368635/ https://ncbi.nlm.nih.gov/pubmed/22778808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100059u |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|